Immune-Mediated Inflammatory Diseases Treatment Market Report

Global and Region Immune-Mediated Inflammatory Diseases Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：183
  • REPORT CODE：GMM921822
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Immune-Mediated Inflammatory Diseases Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Immune-Mediated Inflammatory Diseases Treatmentmarket, defines the market attractiveness level of Immune-Mediated Inflammatory Diseases Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Immune-Mediated Inflammatory Diseases Treatment industry, describes the types of Immune-Mediated Inflammatory Diseases Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immune-Mediated Inflammatory Diseases Treatment market and the development prospects and opportunities of Immune-Mediated Inflammatory Diseases Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immune-Mediated Inflammatory Diseases Treatment market in Chapter 13.

    By Player:

    • Eli Lilly

    • GlaxoSmithKline

    • Sanofi

    • Enlivex Therapeutics

    • Immune Pharmaceuticals

    • AstraZeneca

    • Bristol-Myers

    • Tanabe Pharma

    • Roche

    By Type:

    • Targeted biologic therapies

    • Novel therapies

    By End-User:

    • Hospitals

    • Pharmacy Store

    • Online Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Immune-Mediated Inflammatory Diseases Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Immune-Mediated Inflammatory Diseases Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Immune-Mediated Inflammatory Diseases Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Immune-Mediated Inflammatory Diseases Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Immune-Mediated Inflammatory Diseases Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.2 United States Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.4 China Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.5 Japan Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.6 India Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    • 7.7 South Korea Immune-Mediated Inflammatory Diseases Treatment Consumption (2017-2022)

    8 Region and Country-wise Immune-Mediated Inflammatory Diseases Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.4 China Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.6 India Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast (2022-2028)

    9 Global Immune-Mediated Inflammatory Diseases Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Targeted biologic therapies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Novel therapies Consumption and Growth Rate (2017-2022)

    • 9.2 Global Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacy Store Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global Immune-Mediated Inflammatory Diseases Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Targeted biologic therapies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Novel therapies Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmacy Store Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Immune-Mediated Inflammatory Diseases Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Immune-Mediated Inflammatory Diseases Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Immune-Mediated Inflammatory Diseases Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Immune-Mediated Inflammatory Diseases Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Immune-Mediated Inflammatory Diseases Treatment Market Competitive Analysis

    • 14.1 Eli Lilly

      • 14.1.1 Eli Lilly Company Details

      • 14.1.2 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.4 Enlivex Therapeutics

      • 14.4.1 Enlivex Therapeutics Company Details

      • 14.4.2 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.5 Immune Pharmaceuticals

      • 14.5.1 Immune Pharmaceuticals Company Details

      • 14.5.2 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.6 AstraZeneca

      • 14.6.1 AstraZeneca Company Details

      • 14.6.2 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.7 Bristol-Myers

      • 14.7.1 Bristol-Myers Company Details

      • 14.7.2 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.8 Tanabe Pharma

      • 14.8.1 Tanabe Pharma Company Details

      • 14.8.2 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • 14.9 Roche

      • 14.9.1 Roche Company Details

      • 14.9.2 Roche Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Roche Immune-Mediated Inflammatory Diseases Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Immune-Mediated Inflammatory Diseases Treatment

    • Figure Immune-Mediated Inflammatory Diseases Treatment Picture

    • Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immune-Mediated Inflammatory Diseases Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Immune-Mediated Inflammatory Diseases Treatment Consumption by Country (2017-2022)

    • Figure United States Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Immune-Mediated Inflammatory Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted biologic therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Novel therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Store Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted biologic therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Novel therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Immune-Mediated Inflammatory Diseases Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Immune-Mediated Inflammatory Diseases Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Enlivex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Immune Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Bristol-Myers (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Immune-Mediated Inflammatory Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Immune-Mediated Inflammatory Diseases Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US